Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story?
J Crohns Colitis
.
2021 Jul 5;15(7):1087-1088.
doi: 10.1093/ecco-jcc/jjab006.
Authors
Lucas Guillo
1
,
Laurent Peyrin-Biroulet
2
,
Edouard Louis
3
Affiliations
1
Department of Gastroenterology, University Hospital of Marseille Nord, University of Aix-Marseille, Marseille, France.
2
Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
3
Department of Gastroenterology, Liège University Hospital, CHU Liège, Belgium.
PMID:
33619541
DOI:
10.1093/ecco-jcc/jjab006
No abstract available
Publication types
Editorial
Comment
MeSH terms
Colitis, Ulcerative* / drug therapy
Humans
Piperidines / therapeutic use
Pyrimidines
Pyrroles
Substances
Piperidines
Pyrimidines
Pyrroles
tofacitinib